Wednesday, January 31, 2018

FDA Should Drop Ban On Office Compounding, US House Members ...

https://pink.pharmaintelligence.informa.com/.../fda-should-drop-ban-on-office-comp...
16 hours ago - Executive Summary. Commissioner Gottlieb stands pat (actually he was sitting) during hearing where lawmakers suggest FDA has gone overboard in implementing DQSA. And while he acknowledges that '503 lite' isn't the best term to use, Gottlieb says agency's plan to create different risk tiers for drug outsourcing ...
Post a Comment